Sierra Oncology SRRA

$ 54.89 -0.05%

Quarterly report 2022-Q1
added 12-16-2023

Sierra Oncology Financial Statements 2011-2024 | SRRA

Annual Financial Statements Sierra Oncology

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	288 M	167 M	1.59 B	3.74 B	7.44 B	1.65 B	4.77 B	-	-	-	-
Shares	13.3 M	10.4 M	2.91 M	1.77 M	1.25 M	756 K	360 K	-	-	-	-
Historical Prices	21.7	16	547	2.11 K	5.97 K	2.38 K	24.1 K	-	-	-	-
Net Income	-94.7 M	-80.9 M	-88.3 M	-53.3 M	-42 M	-47.9 M	-53.3 M	-23.9 M	-6.83 M	-	-
Revenue	-	300 K	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	300	-	-	-	-	-	-	-	-	-
Operating Income	-94.6 M	-64.9 M	-67 M	-55.4 M	-42.6 M	-48.1 M	-35.8 M	-22.6 M	-4 M	-	-
Interest Expense	-77 K	421 K	-517 K	1.78 M	760 K	351 K	66 K	87 K	2.72 M	-	-
EBITDA	-94.3 M	-64.7 M	-66.9 M	-55.3 M	-42.4 M	-47.9 M	-35.7 M	-22.5 M	-3.91 M	-	-
Operating Expenses	94.6 M	65.2 M	67 M	55.4 M	42.6 M	48.1 M	35.8 M	-	-	-	-
General and Administrative Expenses	27.4 M	20.1 M	13.7 M	14.3 M	12.5 M	14.2 M	9.47 M	3.5 M	1.16 M	-	-

All numbers in USD currency

Quarterly Income Statement Sierra Oncology

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	21 M	15.6 M	13.7 M	12.4 M	11.7 M	11.1 M	10.4 M	10.4 M	10.2 M	1.87 M	1.87 M	1.87 M	1.86 M	1.86 M	74.3 M	74.3 M	59.7 M	52.4 M	52.3 M	52.3 M	42.6 M	30.4 M	30.3 M	30.2 M	30.1 M	30.1 M	24.2 M	1.5 M	1.49 M	1.59 M	1.02 M	920 K	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-27.9 M	-	-28.6 M	-20.6 M	-19.9 M	-18 M	-14.5 M	-16.5 M	-31.9 M	-47.5 M	-12.9 M	-14.9 M	-13 M	-14.3 M	-15.6 M	-12 M	-11.5 M	-10.6 M	-10 M	-10.3 M	-11.1 M	-9.25 M	-15.2 M	-12.9 M	-10.5 M	-11.5 M	-53.3 M	-53.3 M	-53.3 M	-3.62 M	-3.96 M	-13.8 M	-2.47 M	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	-	-	-	200 K	100 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-27.9 M	-	-28.6 M	-20.6 M	-19.8 M	-	-14.4 M	-16.4 M	-16.1 M	-	-13.3 M	-15.2 M	-13.5 M	-	-16.1 M	-13 M	-11.8 M	-	-10.2 M	-10.5 M	-11.2 M	-	-15.3 M	-12.9 M	-10.6 M	-	-11 M	-6.61 M	-6.74 M	-	-3.48 M	-13.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-59 K	-	3 K	48 K	-29 K	-	-22 K	24 K	541 K	-	288 K	348 K	325 K	-	479 K	582 K	272 K	-	225 K	185 K	96 K	-	88 K	88 K	83 K	-	29 K	-6 K	25 K	-	22 K	31 K	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-27.8 M	-	-28.6 M	-20.6 M	-19.8 M	-	-14.3 M	-16.3 M	-16.1 M	-	-13.1 M	-15.1 M	-13.4 M	-	-16 M	-12.9 M	-11.7 M	-	-10.1 M	-10.4 M	-11.1 M	-	-15.2 M	-12.9 M	-10.6 M	-	-11 M	-6.59 M	-6.72 M	-	-3.48 M	-13.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	27.9 M	-	28.6 M	20.6 M	19.8 M	18.1 M	14.5 M	16.4 M	16.1 M	25 M	13.3 M	15.2 M	13.5 M	14.6 M	16.1 M	13 M	11.8 M	10.8 M	10.2 M	10.5 M	11.2 M	9.23 M	15.3 M	12.9 M	10.6 M	11.4 M	11 M	6.61 M	6.74 M	3.27 M	3.48 M	13.5 M	2.32 M	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	10.3 M	-	6.98 M	6.42 M	5.86 M	-	4.11 M	6.26 M	4.54 M	-	3.15 M	3.48 M	3.36 M	-	3.14 M	4.18 M	3.42 M	-	2.78 M	3.28 M	3.15 M	-	2.96 M	3.83 M	3.98 M	-	2.74 M	1.87 M	1.44 M	-	1.04 M	791 K	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency